CDC37 and glioblastoma: Cdc37 Ser13 phosphorylation in glioblastoma tumors was also significantly reduced in mice injected with compound 4 suggesting that at least part of the antitumoral effect of this class of inhibitors could involve inhibition of Cdc37.